nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—Mental disorder—Docetaxel—ovarian cancer	0.0011	0.0011	CcSEcCtD
Fosaprepitant—Chest pain—Paclitaxel—ovarian cancer	0.0011	0.0011	CcSEcCtD
Fosaprepitant—Anxiety—Paclitaxel—ovarian cancer	0.00109	0.00109	CcSEcCtD
Fosaprepitant—Erythema—Docetaxel—ovarian cancer	0.00109	0.00109	CcSEcCtD
Fosaprepitant—Malnutrition—Docetaxel—ovarian cancer	0.00109	0.00109	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00109	0.00109	CcSEcCtD
Fosaprepitant—Nausea—Topotecan—ovarian cancer	0.00109	0.00109	CcSEcCtD
Fosaprepitant—Discomfort—Paclitaxel—ovarian cancer	0.00108	0.00108	CcSEcCtD
Fosaprepitant—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Fosaprepitant—Muscular weakness—Epirubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Fosaprepitant—Dry mouth—Paclitaxel—ovarian cancer	0.00107	0.00107	CcSEcCtD
Fosaprepitant—Diarrhoea—Vinorelbine—ovarian cancer	0.00107	0.00107	CcSEcCtD
Fosaprepitant—Dysgeusia—Docetaxel—ovarian cancer	0.00107	0.00107	CcSEcCtD
Fosaprepitant—Abdominal distension—Epirubicin—ovarian cancer	0.00106	0.00106	CcSEcCtD
Fosaprepitant—Nausea—Melphalan—ovarian cancer	0.00106	0.00106	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00105	0.00105	CcSEcCtD
Fosaprepitant—Oedema—Paclitaxel—ovarian cancer	0.00105	0.00105	CcSEcCtD
Fosaprepitant—Muscle spasms—Docetaxel—ovarian cancer	0.00105	0.00105	CcSEcCtD
Fosaprepitant—Infection—Paclitaxel—ovarian cancer	0.00104	0.00104	CcSEcCtD
Fosaprepitant—Shock—Paclitaxel—ovarian cancer	0.00103	0.00103	CcSEcCtD
Fosaprepitant—Dizziness—Vinorelbine—ovarian cancer	0.00103	0.00103	CcSEcCtD
Fosaprepitant—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00103	0.00103	CcSEcCtD
Fosaprepitant—Nervous system disorder—Paclitaxel—ovarian cancer	0.00103	0.00103	CcSEcCtD
Fosaprepitant—Hypokalaemia—Doxorubicin—ovarian cancer	0.00103	0.00103	CcSEcCtD
Fosaprepitant—Skin disorder—Paclitaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Fosaprepitant—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00102	0.00102	CcSEcCtD
Fosaprepitant—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.00102	0.00102	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Fosaprepitant—Anaemia—Docetaxel—ovarian cancer	0.00101	0.00101	CcSEcCtD
Fosaprepitant—Muscular weakness—Doxorubicin—ovarian cancer	0.000998	0.000998	CcSEcCtD
Fosaprepitant—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000998	0.000998	CcSEcCtD
Fosaprepitant—Vomiting—Vinorelbine—ovarian cancer	0.000994	0.000994	CcSEcCtD
Fosaprepitant—Dysuria—Epirubicin—ovarian cancer	0.000988	0.000988	CcSEcCtD
Fosaprepitant—Rash—Vinorelbine—ovarian cancer	0.000985	0.000985	CcSEcCtD
Fosaprepitant—Dermatitis—Vinorelbine—ovarian cancer	0.000985	0.000985	CcSEcCtD
Fosaprepitant—Abdominal distension—Doxorubicin—ovarian cancer	0.000984	0.000984	CcSEcCtD
Fosaprepitant—Hypotension—Paclitaxel—ovarian cancer	0.000982	0.000982	CcSEcCtD
Fosaprepitant—Headache—Vinorelbine—ovarian cancer	0.000979	0.000979	CcSEcCtD
Fosaprepitant—Syncope—Docetaxel—ovarian cancer	0.000979	0.000979	CcSEcCtD
Fosaprepitant—Pollakiuria—Epirubicin—ovarian cancer	0.000976	0.000976	CcSEcCtD
Fosaprepitant—Palpitations—Docetaxel—ovarian cancer	0.000965	0.000965	CcSEcCtD
Fosaprepitant—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000965	0.000965	CcSEcCtD
Fosaprepitant—Loss of consciousness—Docetaxel—ovarian cancer	0.00096	0.00096	CcSEcCtD
Fosaprepitant—Weight decreased—Epirubicin—ovarian cancer	0.000956	0.000956	CcSEcCtD
Fosaprepitant—Cough—Docetaxel—ovarian cancer	0.000953	0.000953	CcSEcCtD
Fosaprepitant—Insomnia—Paclitaxel—ovarian cancer	0.000951	0.000951	CcSEcCtD
Fosaprepitant—Hypertension—Docetaxel—ovarian cancer	0.000943	0.000943	CcSEcCtD
Fosaprepitant—Infestation NOS—Epirubicin—ovarian cancer	0.000942	0.000942	CcSEcCtD
Fosaprepitant—Infestation—Epirubicin—ovarian cancer	0.000942	0.000942	CcSEcCtD
Fosaprepitant—Dyspnoea—Paclitaxel—ovarian cancer	0.000937	0.000937	CcSEcCtD
Fosaprepitant—Somnolence—Paclitaxel—ovarian cancer	0.000935	0.000935	CcSEcCtD
Fosaprepitant—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000934	0.000934	CcSEcCtD
Fosaprepitant—Chest pain—Docetaxel—ovarian cancer	0.000929	0.000929	CcSEcCtD
Fosaprepitant—Nausea—Vinorelbine—ovarian cancer	0.000928	0.000928	CcSEcCtD
Fosaprepitant—Dyspepsia—Paclitaxel—ovarian cancer	0.000925	0.000925	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000923	0.000923	CcSEcCtD
Fosaprepitant—Stomatitis—Epirubicin—ovarian cancer	0.000919	0.000919	CcSEcCtD
Fosaprepitant—Conjunctivitis—Epirubicin—ovarian cancer	0.000916	0.000916	CcSEcCtD
Fosaprepitant—Urinary tract infection—Epirubicin—ovarian cancer	0.000916	0.000916	CcSEcCtD
Fosaprepitant—Dysuria—Doxorubicin—ovarian cancer	0.000914	0.000914	CcSEcCtD
Fosaprepitant—Decreased appetite—Paclitaxel—ovarian cancer	0.000914	0.000914	CcSEcCtD
Fosaprepitant—Dry mouth—Docetaxel—ovarian cancer	0.000909	0.000909	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000908	0.000908	CcSEcCtD
Fosaprepitant—Fatigue—Paclitaxel—ovarian cancer	0.000906	0.000906	CcSEcCtD
Fosaprepitant—Pollakiuria—Doxorubicin—ovarian cancer	0.000903	0.000903	CcSEcCtD
Fosaprepitant—Pain—Paclitaxel—ovarian cancer	0.000899	0.000899	CcSEcCtD
Fosaprepitant—Constipation—Paclitaxel—ovarian cancer	0.000899	0.000899	CcSEcCtD
Fosaprepitant—Haematuria—Epirubicin—ovarian cancer	0.000898	0.000898	CcSEcCtD
Fosaprepitant—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000893	0.000893	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Docetaxel—ovarian cancer	0.000891	0.000891	CcSEcCtD
Fosaprepitant—Oedema—Docetaxel—ovarian cancer	0.000891	0.000891	CcSEcCtD
Fosaprepitant—Infection—Docetaxel—ovarian cancer	0.000885	0.000885	CcSEcCtD
Fosaprepitant—Weight decreased—Doxorubicin—ovarian cancer	0.000885	0.000885	CcSEcCtD
Fosaprepitant—Shock—Docetaxel—ovarian cancer	0.000877	0.000877	CcSEcCtD
Fosaprepitant—Nervous system disorder—Docetaxel—ovarian cancer	0.000874	0.000874	CcSEcCtD
Fosaprepitant—Infestation—Doxorubicin—ovarian cancer	0.000872	0.000872	CcSEcCtD
Fosaprepitant—Infestation NOS—Doxorubicin—ovarian cancer	0.000872	0.000872	CcSEcCtD
Fosaprepitant—Feeling abnormal—Paclitaxel—ovarian cancer	0.000866	0.000866	CcSEcCtD
Fosaprepitant—Skin disorder—Docetaxel—ovarian cancer	0.000865	0.000865	CcSEcCtD
Fosaprepitant—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000864	0.000864	CcSEcCtD
Fosaprepitant—Bradycardia—Epirubicin—ovarian cancer	0.000861	0.000861	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00086	0.00086	CcSEcCtD
Fosaprepitant—Stomatitis—Doxorubicin—ovarian cancer	0.00085	0.00085	CcSEcCtD
Fosaprepitant—Conjunctivitis—Doxorubicin—ovarian cancer	0.000848	0.000848	CcSEcCtD
Fosaprepitant—Urinary tract infection—Doxorubicin—ovarian cancer	0.000848	0.000848	CcSEcCtD
Fosaprepitant—Hypoaesthesia—Epirubicin—ovarian cancer	0.000842	0.000842	CcSEcCtD
Fosaprepitant—Urinary tract disorder—Epirubicin—ovarian cancer	0.000835	0.000835	CcSEcCtD
Fosaprepitant—Urticaria—Paclitaxel—ovarian cancer	0.000835	0.000835	CcSEcCtD
Fosaprepitant—Hypotension—Docetaxel—ovarian cancer	0.000833	0.000833	CcSEcCtD
Fosaprepitant—Haematuria—Doxorubicin—ovarian cancer	0.000831	0.000831	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Epirubicin—ovarian cancer	0.000831	0.000831	CcSEcCtD
Fosaprepitant—Body temperature increased—Paclitaxel—ovarian cancer	0.000831	0.000831	CcSEcCtD
Fosaprepitant—Abdominal pain—Paclitaxel—ovarian cancer	0.000831	0.000831	CcSEcCtD
Fosaprepitant—Urethral disorder—Epirubicin—ovarian cancer	0.000829	0.000829	CcSEcCtD
Fosaprepitant—Insomnia—Docetaxel—ovarian cancer	0.000806	0.000806	CcSEcCtD
Fosaprepitant—Erythema multiforme—Epirubicin—ovarian cancer	0.0008	0.0008	CcSEcCtD
Fosaprepitant—Bradycardia—Doxorubicin—ovarian cancer	0.000797	0.000797	CcSEcCtD
Fosaprepitant—Dyspnoea—Docetaxel—ovarian cancer	0.000794	0.000794	CcSEcCtD
Fosaprepitant—Somnolence—Docetaxel—ovarian cancer	0.000792	0.000792	CcSEcCtD
Fosaprepitant—Eye disorder—Epirubicin—ovarian cancer	0.000791	0.000791	CcSEcCtD
Fosaprepitant—Tinnitus—Epirubicin—ovarian cancer	0.000789	0.000789	CcSEcCtD
Fosaprepitant—Cardiac disorder—Epirubicin—ovarian cancer	0.000785	0.000785	CcSEcCtD
Fosaprepitant—Flushing—Epirubicin—ovarian cancer	0.000785	0.000785	CcSEcCtD
Fosaprepitant—Dyspepsia—Docetaxel—ovarian cancer	0.000784	0.000784	CcSEcCtD
Fosaprepitant—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000779	0.000779	CcSEcCtD
Fosaprepitant—Decreased appetite—Docetaxel—ovarian cancer	0.000775	0.000775	CcSEcCtD
Fosaprepitant—Hypersensitivity—Paclitaxel—ovarian cancer	0.000775	0.000775	CcSEcCtD
Fosaprepitant—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000773	0.000773	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000769	0.000769	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000769	0.000769	CcSEcCtD
Fosaprepitant—Fatigue—Docetaxel—ovarian cancer	0.000768	0.000768	CcSEcCtD
Fosaprepitant—Angiopathy—Epirubicin—ovarian cancer	0.000767	0.000767	CcSEcCtD
Fosaprepitant—Urethral disorder—Doxorubicin—ovarian cancer	0.000767	0.000767	CcSEcCtD
Fosaprepitant—Immune system disorder—Epirubicin—ovarian cancer	0.000764	0.000764	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Epirubicin—ovarian cancer	0.000762	0.000762	CcSEcCtD
Fosaprepitant—Pain—Docetaxel—ovarian cancer	0.000762	0.000762	CcSEcCtD
Fosaprepitant—Constipation—Docetaxel—ovarian cancer	0.000762	0.000762	CcSEcCtD
Fosaprepitant—Asthenia—Paclitaxel—ovarian cancer	0.000754	0.000754	CcSEcCtD
Fosaprepitant—Pruritus—Paclitaxel—ovarian cancer	0.000744	0.000744	CcSEcCtD
Fosaprepitant—Mental disorder—Epirubicin—ovarian cancer	0.000741	0.000741	CcSEcCtD
Fosaprepitant—Erythema multiforme—Doxorubicin—ovarian cancer	0.00074	0.00074	CcSEcCtD
Fosaprepitant—Erythema—Epirubicin—ovarian cancer	0.000736	0.000736	CcSEcCtD
Fosaprepitant—Malnutrition—Epirubicin—ovarian cancer	0.000736	0.000736	CcSEcCtD
Fosaprepitant—Feeling abnormal—Docetaxel—ovarian cancer	0.000734	0.000734	CcSEcCtD
Fosaprepitant—Eye disorder—Doxorubicin—ovarian cancer	0.000731	0.000731	CcSEcCtD
Fosaprepitant—Tinnitus—Doxorubicin—ovarian cancer	0.00073	0.00073	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000729	0.000729	CcSEcCtD
Fosaprepitant—Cardiac disorder—Doxorubicin—ovarian cancer	0.000726	0.000726	CcSEcCtD
Fosaprepitant—Flushing—Doxorubicin—ovarian cancer	0.000726	0.000726	CcSEcCtD
Fosaprepitant—Flatulence—Epirubicin—ovarian cancer	0.000726	0.000726	CcSEcCtD
Fosaprepitant—Dysgeusia—Epirubicin—ovarian cancer	0.000721	0.000721	CcSEcCtD
Fosaprepitant—Diarrhoea—Paclitaxel—ovarian cancer	0.000719	0.000719	CcSEcCtD
Fosaprepitant—Angiopathy—Doxorubicin—ovarian cancer	0.00071	0.00071	CcSEcCtD
Fosaprepitant—Muscle spasms—Epirubicin—ovarian cancer	0.000708	0.000708	CcSEcCtD
Fosaprepitant—Immune system disorder—Doxorubicin—ovarian cancer	0.000707	0.000707	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000705	0.000705	CcSEcCtD
Fosaprepitant—Body temperature increased—Docetaxel—ovarian cancer	0.000704	0.000704	CcSEcCtD
Fosaprepitant—Abdominal pain—Docetaxel—ovarian cancer	0.000704	0.000704	CcSEcCtD
Fosaprepitant—Dizziness—Paclitaxel—ovarian cancer	0.000695	0.000695	CcSEcCtD
Fosaprepitant—Mental disorder—Doxorubicin—ovarian cancer	0.000686	0.000686	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Epirubicin—ovarian cancer	0.000683	0.000683	CcSEcCtD
Fosaprepitant—Erythema—Doxorubicin—ovarian cancer	0.000681	0.000681	CcSEcCtD
Fosaprepitant—Malnutrition—Doxorubicin—ovarian cancer	0.000681	0.000681	CcSEcCtD
Fosaprepitant—Anaemia—Epirubicin—ovarian cancer	0.000681	0.000681	CcSEcCtD
Fosaprepitant—Flatulence—Doxorubicin—ovarian cancer	0.000671	0.000671	CcSEcCtD
Fosaprepitant—Vomiting—Paclitaxel—ovarian cancer	0.000668	0.000668	CcSEcCtD
Fosaprepitant—Dysgeusia—Doxorubicin—ovarian cancer	0.000667	0.000667	CcSEcCtD
Fosaprepitant—Malaise—Epirubicin—ovarian cancer	0.000664	0.000664	CcSEcCtD
Fosaprepitant—Rash—Paclitaxel—ovarian cancer	0.000663	0.000663	CcSEcCtD
Fosaprepitant—Dermatitis—Paclitaxel—ovarian cancer	0.000662	0.000662	CcSEcCtD
Fosaprepitant—Syncope—Epirubicin—ovarian cancer	0.00066	0.00066	CcSEcCtD
Fosaprepitant—Headache—Paclitaxel—ovarian cancer	0.000659	0.000659	CcSEcCtD
Fosaprepitant—Hypersensitivity—Docetaxel—ovarian cancer	0.000656	0.000656	CcSEcCtD
Fosaprepitant—Muscle spasms—Doxorubicin—ovarian cancer	0.000655	0.000655	CcSEcCtD
Fosaprepitant—Palpitations—Epirubicin—ovarian cancer	0.000651	0.000651	CcSEcCtD
Fosaprepitant—Loss of consciousness—Epirubicin—ovarian cancer	0.000647	0.000647	CcSEcCtD
Fosaprepitant—Cough—Epirubicin—ovarian cancer	0.000643	0.000643	CcSEcCtD
Fosaprepitant—Asthenia—Docetaxel—ovarian cancer	0.000639	0.000639	CcSEcCtD
Fosaprepitant—Hypertension—Epirubicin—ovarian cancer	0.000636	0.000636	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000632	0.000632	CcSEcCtD
Fosaprepitant—Pruritus—Docetaxel—ovarian cancer	0.00063	0.00063	CcSEcCtD
Fosaprepitant—Anaemia—Doxorubicin—ovarian cancer	0.00063	0.00063	CcSEcCtD
Fosaprepitant—Chest pain—Epirubicin—ovarian cancer	0.000627	0.000627	CcSEcCtD
Fosaprepitant—Anxiety—Epirubicin—ovarian cancer	0.000625	0.000625	CcSEcCtD
Fosaprepitant—Nausea—Paclitaxel—ovarian cancer	0.000624	0.000624	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000623	0.000623	CcSEcCtD
Fosaprepitant—Discomfort—Epirubicin—ovarian cancer	0.000619	0.000619	CcSEcCtD
Fosaprepitant—Malaise—Doxorubicin—ovarian cancer	0.000614	0.000614	CcSEcCtD
Fosaprepitant—Dry mouth—Epirubicin—ovarian cancer	0.000613	0.000613	CcSEcCtD
Fosaprepitant—Syncope—Doxorubicin—ovarian cancer	0.000611	0.000611	CcSEcCtD
Fosaprepitant—Diarrhoea—Docetaxel—ovarian cancer	0.00061	0.00061	CcSEcCtD
Fosaprepitant—Palpitations—Doxorubicin—ovarian cancer	0.000602	0.000602	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Epirubicin—ovarian cancer	0.000601	0.000601	CcSEcCtD
Fosaprepitant—Oedema—Epirubicin—ovarian cancer	0.000601	0.000601	CcSEcCtD
Fosaprepitant—Loss of consciousness—Doxorubicin—ovarian cancer	0.000599	0.000599	CcSEcCtD
Fosaprepitant—Infection—Epirubicin—ovarian cancer	0.000597	0.000597	CcSEcCtD
Fosaprepitant—Cough—Doxorubicin—ovarian cancer	0.000595	0.000595	CcSEcCtD
Fosaprepitant—Shock—Epirubicin—ovarian cancer	0.000591	0.000591	CcSEcCtD
Fosaprepitant—Nervous system disorder—Epirubicin—ovarian cancer	0.000589	0.000589	CcSEcCtD
Fosaprepitant—Dizziness—Docetaxel—ovarian cancer	0.000589	0.000589	CcSEcCtD
Fosaprepitant—Hypertension—Doxorubicin—ovarian cancer	0.000588	0.000588	CcSEcCtD
Fosaprepitant—Skin disorder—Epirubicin—ovarian cancer	0.000584	0.000584	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Epirubicin—ovarian cancer	0.000581	0.000581	CcSEcCtD
Fosaprepitant—Chest pain—Doxorubicin—ovarian cancer	0.00058	0.00058	CcSEcCtD
Fosaprepitant—Anxiety—Doxorubicin—ovarian cancer	0.000578	0.000578	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000576	0.000576	CcSEcCtD
Fosaprepitant—Discomfort—Doxorubicin—ovarian cancer	0.000573	0.000573	CcSEcCtD
Fosaprepitant—Dry mouth—Doxorubicin—ovarian cancer	0.000567	0.000567	CcSEcCtD
Fosaprepitant—Vomiting—Docetaxel—ovarian cancer	0.000567	0.000567	CcSEcCtD
Fosaprepitant—Rash—Docetaxel—ovarian cancer	0.000562	0.000562	CcSEcCtD
Fosaprepitant—Hypotension—Epirubicin—ovarian cancer	0.000562	0.000562	CcSEcCtD
Fosaprepitant—Dermatitis—Docetaxel—ovarian cancer	0.000561	0.000561	CcSEcCtD
Fosaprepitant—Headache—Docetaxel—ovarian cancer	0.000558	0.000558	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000556	0.000556	CcSEcCtD
Fosaprepitant—Oedema—Doxorubicin—ovarian cancer	0.000556	0.000556	CcSEcCtD
Fosaprepitant—Infection—Doxorubicin—ovarian cancer	0.000552	0.000552	CcSEcCtD
Fosaprepitant—Shock—Doxorubicin—ovarian cancer	0.000547	0.000547	CcSEcCtD
Fosaprepitant—Nervous system disorder—Doxorubicin—ovarian cancer	0.000545	0.000545	CcSEcCtD
Fosaprepitant—Insomnia—Epirubicin—ovarian cancer	0.000544	0.000544	CcSEcCtD
Fosaprepitant—Skin disorder—Doxorubicin—ovarian cancer	0.00054	0.00054	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000538	0.000538	CcSEcCtD
Fosaprepitant—Dyspnoea—Epirubicin—ovarian cancer	0.000536	0.000536	CcSEcCtD
Fosaprepitant—Somnolence—Epirubicin—ovarian cancer	0.000534	0.000534	CcSEcCtD
Fosaprepitant—Nausea—Docetaxel—ovarian cancer	0.000529	0.000529	CcSEcCtD
Fosaprepitant—Dyspepsia—Epirubicin—ovarian cancer	0.000529	0.000529	CcSEcCtD
Fosaprepitant—Decreased appetite—Epirubicin—ovarian cancer	0.000522	0.000522	CcSEcCtD
Fosaprepitant—Hypotension—Doxorubicin—ovarian cancer	0.00052	0.00052	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000519	0.000519	CcSEcCtD
Fosaprepitant—Fatigue—Epirubicin—ovarian cancer	0.000518	0.000518	CcSEcCtD
Fosaprepitant—Pain—Epirubicin—ovarian cancer	0.000514	0.000514	CcSEcCtD
Fosaprepitant—Constipation—Epirubicin—ovarian cancer	0.000514	0.000514	CcSEcCtD
Fosaprepitant—Insomnia—Doxorubicin—ovarian cancer	0.000503	0.000503	CcSEcCtD
Fosaprepitant—Dyspnoea—Doxorubicin—ovarian cancer	0.000496	0.000496	CcSEcCtD
Fosaprepitant—Feeling abnormal—Epirubicin—ovarian cancer	0.000495	0.000495	CcSEcCtD
Fosaprepitant—Somnolence—Doxorubicin—ovarian cancer	0.000494	0.000494	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000491	0.000491	CcSEcCtD
Fosaprepitant—Dyspepsia—Doxorubicin—ovarian cancer	0.00049	0.00049	CcSEcCtD
Fosaprepitant—Decreased appetite—Doxorubicin—ovarian cancer	0.000483	0.000483	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00048	0.00048	CcSEcCtD
Fosaprepitant—Fatigue—Doxorubicin—ovarian cancer	0.000479	0.000479	CcSEcCtD
Fosaprepitant—Urticaria—Epirubicin—ovarian cancer	0.000477	0.000477	CcSEcCtD
Fosaprepitant—Pain—Doxorubicin—ovarian cancer	0.000476	0.000476	CcSEcCtD
Fosaprepitant—Constipation—Doxorubicin—ovarian cancer	0.000476	0.000476	CcSEcCtD
Fosaprepitant—Abdominal pain—Epirubicin—ovarian cancer	0.000475	0.000475	CcSEcCtD
Fosaprepitant—Body temperature increased—Epirubicin—ovarian cancer	0.000475	0.000475	CcSEcCtD
Fosaprepitant—Feeling abnormal—Doxorubicin—ovarian cancer	0.000458	0.000458	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000455	0.000455	CcSEcCtD
Fosaprepitant—Hypersensitivity—Epirubicin—ovarian cancer	0.000443	0.000443	CcSEcCtD
Fosaprepitant—Urticaria—Doxorubicin—ovarian cancer	0.000442	0.000442	CcSEcCtD
Fosaprepitant—Body temperature increased—Doxorubicin—ovarian cancer	0.00044	0.00044	CcSEcCtD
Fosaprepitant—Abdominal pain—Doxorubicin—ovarian cancer	0.00044	0.00044	CcSEcCtD
Fosaprepitant—Asthenia—Epirubicin—ovarian cancer	0.000431	0.000431	CcSEcCtD
Fosaprepitant—Pruritus—Epirubicin—ovarian cancer	0.000425	0.000425	CcSEcCtD
Fosaprepitant—Diarrhoea—Epirubicin—ovarian cancer	0.000411	0.000411	CcSEcCtD
Fosaprepitant—Hypersensitivity—Doxorubicin—ovarian cancer	0.00041	0.00041	CcSEcCtD
Fosaprepitant—Asthenia—Doxorubicin—ovarian cancer	0.000399	0.000399	CcSEcCtD
Fosaprepitant—Dizziness—Epirubicin—ovarian cancer	0.000397	0.000397	CcSEcCtD
Fosaprepitant—Pruritus—Doxorubicin—ovarian cancer	0.000393	0.000393	CcSEcCtD
Fosaprepitant—Vomiting—Epirubicin—ovarian cancer	0.000382	0.000382	CcSEcCtD
Fosaprepitant—Diarrhoea—Doxorubicin—ovarian cancer	0.00038	0.00038	CcSEcCtD
Fosaprepitant—Rash—Epirubicin—ovarian cancer	0.000379	0.000379	CcSEcCtD
Fosaprepitant—Dermatitis—Epirubicin—ovarian cancer	0.000379	0.000379	CcSEcCtD
Fosaprepitant—Headache—Epirubicin—ovarian cancer	0.000377	0.000377	CcSEcCtD
Fosaprepitant—Dizziness—Doxorubicin—ovarian cancer	0.000368	0.000368	CcSEcCtD
Fosaprepitant—Nausea—Epirubicin—ovarian cancer	0.000357	0.000357	CcSEcCtD
Fosaprepitant—Vomiting—Doxorubicin—ovarian cancer	0.000354	0.000354	CcSEcCtD
Fosaprepitant—Rash—Doxorubicin—ovarian cancer	0.000351	0.000351	CcSEcCtD
Fosaprepitant—Dermatitis—Doxorubicin—ovarian cancer	0.00035	0.00035	CcSEcCtD
Fosaprepitant—Headache—Doxorubicin—ovarian cancer	0.000348	0.000348	CcSEcCtD
Fosaprepitant—Nausea—Doxorubicin—ovarian cancer	0.00033	0.00033	CcSEcCtD
